Medicare will pay for early Alzheimer's blood tests starting 2028
H.R. 6130 — ASAP Act · Filed by Vern Buchanan (R-FL) · 217 cosponsors · Introduced Nov 19, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill changes Medicare rules to pay for blood tests. The tests find early signs of Alzheimer's disease and similar brain problems. Tests must be approved by the FDA. Medicare will cover these tests starting January 1, 2028.
Who it affects
Medicare beneficiaries can get these blood tests without paying. The tests help find Alzheimer's early, when treatment might work better.
One thing to notice
The bill does not say how much Medicare will pay for these tests. The payment amount will be decided later.
From the analysis of the bill text, linked under Primary records below.
Where it stands
217 cosponsors: 130 Democrats, 86 Republicans, 1 Independents.
- Nov 19, 2025 — Introduced · Congress.gov: “Introduced in House”
- Nov 19, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
- Sep 16, 2026 — Markup held in committee · Congress.gov: “Committee Consideration and Mark-up Session Held”
- Sep 16, 2026 — Reported out of committee · Congress.gov: “Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
13 groups reported lobbying about this bill. They filed 16 reports from Dec 2025 to Jun 2026.
Those reports show $4,990,000 in lobbying spending. Each report lists about 9 bills. So that money was not all for this bill.
More groups named this bill than 94% of bills with any report.
Vern Buchanan, who sponsored the bill, received $544,700 from PACs for the 2026 election.
- Eisai Inc. — $1,500,000 in 2 reports
- Biogen — $1,060,000 in 1 report
- Acadia Pharmaceuticals — $700,000 in 1 report
- Quest Diagnostics Incorporated — $470,000 in 1 report
- Johns Hopkins University — $350,000 in 1 report
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- Medicare beneficiaries — People who get health insurance through Medicare, mainly older adults.
- FDA — The Food and Drug Administration, the agency that approves medical tests.
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
- sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,825 characters) on Aug 19, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,522 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-09-21.
“Medicare will pay for early Alzheimer's blood tests starting 2028” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6130/simple Report an error